This is a working overview of Anti-doping testing, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-10-08. Anything still debated is marked as such rather than presented as settled.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.
Regulatory treatment of cardarine differs by context and jurisdiction. In competitive sport, the World Anti-Doping Agency lists PPARδ agonists, including GW501516, as prohibited at all times. Outside sport, it lacks approval as a prescription medicine in major drug markets, and products sold for human consumption may be treated as unapproved drugs. Some countries also restrict importation or sale through general consumer protection and medicines laws. These classifications affect availability, testing, and legal risk without establishing therapeutic value.
Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | GW501516; GW-1516; endurobol | GW501516 is the research code |
| Drug class | PPARδ agonist | Not a selective androgen receptor modulator |
| Molecular formula | C21H18F3NO3S2 | Established chemical formula |
| Molar mass | 453.5 g/mol | Calculated from the formula |
| Regulatory status | Prohibited in sport; not approved as medicine | Status varies by country |
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.
Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.
Laboratory detection of GW501516 commonly uses liquid chromatography coupled with tandem mass spectrometry. The method can identify the parent compound or its metabolites in urine and blood after sample cleanup. Protein precipitation, solid-phase extraction, or enzymatic hydrolysis may precede analysis, depending on the matrix. Reference standards are required for accurate quantification and confirmation. Because the compound is not approved, testing often occurs in anti-doping, forensic, or research settings rather than routine clinical care. Results are reported with limits of detection and quantification.
=== Domestic pressures in Israel === Netanyahu has faced charges for corruption, and the war may have helped him avoid dealing with these. The war may also help the Israeli government to overhaul Israel's Supreme Court, mitigate criticism of Israel's treatment of Palestinians, and help Netanyahu with the 2026 Israeli legislative election. The war has made Netanyahu more popular, increasing his approval rating from a tie with Naftali Bennett to 62%. Some analysts suggest that Netanyahu will call for a snap election due to the extra support from the war.
The Latam Pulse survey, carried out by Atlasintel and released on 11 February, showed that President Lula had 45.9% approval and 51.4% disapproval, the worst mark in the historical series. Rejection is higher among men, young people aged 16 to 44, evangelicals, and residents of the Central-West, North, South, and Southeast regions. In the Northeast, the rates are balanced. The overall evaluation of the government also worsened, with 46.5% considering the administration bad or terrible. Concern about the economy doubled, being cited by 29% of Brazilians, behind only crime (58%) and corruption (49%). Inflation is the biggest economic problem, mentioned by 75% of respondents. On tax reform, 41.5% considered it progress in need of improvement, 23% saw it as progress, and 35% classified it as a setback. The Datafolha survey, released by Folha de S.Paulo on 14 February, points to a fall in President Lula's approval, recording the lowest rate of his three terms. According to the survey, 24% of respondents rated the government as excellent or good, while 41% considered it bad or terrible. Another 32% classified the administration as regular, and 2% did not know how to respond. Compared with the previous survey, carried out in December 2024, approval fell from 35% to 24%, while disapproval increased from 34% to 41%. The fall was observed in different segments. Among voters with income of up to two minimum wages, approval fell from 44% to 29%. Among those earning more than ten minimum wages, it went from 32% to 18%.
=== Off-label drugs === α2-Adrenergic receptor agonists (e.g., clonidine, dexmedetomidine, guanfacine) – opioid withdrawal Benzodiazepines (e.g., diazepam) – GABAA receptor positive allosteric modulators – alcohol withdrawal syndrome Gabapentinoids (e.g., gabapentin, pregabalin) – α2δ subunit-containing voltage-gated calcium channel blockers – alcohol withdrawal syndrome Ibogaine (Tabernanthe iboga) – various actions, oneirogen/hallucinogen – opioid use disorder Lobeline – nicotinic acetylcholine receptor agonist – smoking withdrawal Mecamylamine – nicotinic acetylcholine receptor antagonist – smoking withdrawal Nicotine (nicotine replacement therapy; e.g., nicotine gum, nicotine inhaler, nicotine lozenge, nicotine nasal spray, nicotine patch) – nicotinic acetylcholine receptor agonist – smoking withdrawal Phenibut (Anvifen) – GABAB receptor agonist and gabapentinoid (α2δ subunit-containing voltage-gated calcium channel blocker) – alcoholism and alcohol withdrawal syndrome Serotonergic psychedelics (e.g., psilocybin, LSD, mescaline, DMT) – serotonin 5-HT2A receptor agonists and psychedelic hallucinogens – various substance use disorders Topiramate (Topamax) – various actions – alcoholism and alcohol withdrawal syndrome
Sources: en.wikipedia.org
In February 2023, Reuters reported that President Lula would meet with General Secretary of the Chinese Communist Party Xi Jinping during a four-day trip to China on 28 March to hold talks about trade, including green economy, digital inclusion, reindustrialization and the Russia-Ukraine War. On 17 March 2023, Itamaraty confirmed Lula's trip to China, adding that he would also meet with Chinese premier Li Qiang and National People's Congress chairman Zhao Leji. A week later, New Development Bank (NDB), whose headquarters are in Shanghai, elected Brazilian former president Dilma Rousseff as its new CEO after president Lula made his official appointment. On 24 March, however, due to health issues Lula canceled his trip which was later rescheduled for 11–14 April. As part of a separate high-level business forum between Brazilian and Chinese officials and hundreds of business people in Beijing, both countries announced on 29 March they were starting to trade in their own currencies (the Real and the Renmimbi) instead of in the US dollar. In April 2023, President Lula, who was accompanied by many of his cabinet ministers, Brazilian state governors and lawmakers, met with Chinese deputy foreign minister Xie Feng upon their arrival in Shanghai, where Lula also attended Brazilian former president Dilma Rousseff inauguration as the new NDB CEO, visited a Huawei center and spoke with several Chinese chairpeople including BYD CEO Wang Chuanfu and China Communications Construction Company (CCCC) CEO Wang Tongzhou.
== See also == 2,5-Dimethoxyamphetamine 2C, 3C, 4C, scaline, Ψ-PEA, 25-NB, FLY Substituted amphetamines Substituted benzofurans Substituted cathinones Substituted methoxyphenethylamine Substituted methylenedioxyphenethylamines Substituted phenethylamines Substituted tryptamines PiHKAL The Shulgin Index
==== Effects of pH ==== The uranium fraction diagrams in the presence of carbonate illustrate this further: when the pH of a uranium(VI) solution increases, the uranium is converted to a hydrated uranium oxide hydroxide; At high pH, it becomes an anionic hydroxide complex. When carbonate is added, uranium is converted to a series of carbonate complexes if the pH is increased. One effect of these reactions is increased solubility of uranium in the pH range 6 to 8, a fact that has a direct bearing on the long term stability of spent uranium dioxide nuclear fuels.
However, in December 2016, the US took steps to reinstate retaliatory tariffs given continued concerns about EU market access, and in August 2019 they agreed to establish an initial duty-free tariff-rate quota of 18,500 tonnes annually, growing in phases over seven years to 35,000 tonnes (valued at approximately US$420 million) of the EU 45,000 tonnes quota of non-hormone treated beef.
Sources: en.wikipedia.org
== Career == After gaining her doctorate, Ala-Kokko moved to Thomas Jefferson University in Philadelphia, United States, to carry out postdoctoral research in the group of Darwin Prockop. While there, Ala-Kokko focused her attention more directly on describing the structure, function and possible errors in genes that code for collagen proteins. She worked at Thomas Jefferson University as a research associate from 1987 to 1989, and as an instructor from 1989 to 1991. In 1990, Ala-Kokko was granted title of docent by the University of Oulu in the field of medical biochemistry. Her research work continued to be based in Philadelphia until 1997, when she was selected as a senior research fellow by the Academy of Finland. In the same year, Ala-Kokko also started at MCP Hahnemann University as an adjunct associate professor. In 2000, Ala-Kokko started work at the gene therapy centre of Tulane University in New Orleans. She worked there as an associate professor, and later became a full professor with tenure. In 2003 she was named professor of medical biochemistry and molecular biology at the University of Oulu. She left Tulane University in 2004. The company Connective Tissue Gene Tests was founded by Ala-Kokko in 2004 with her husband James Hyland. They offer over a thousand tests which function as molecular diagnostic tests of connective tissue disorders. As of 2018 her responsibility in the company is for research, development and technology. She is also responsible for overseeing all the tests that the company produces.
== Further reading == Arnold D (2010). "British India and the beri-beri problem". Medical History. 54 (3): 295–314. doi:10.1017/S0025727300004622. PMC 2889456. PMID 20592882. Chisholm H, ed. (1911). "Beri-Beri" . Encyclopædia Britannica. Vol. 03 (11th ed.). Cambridge University Press. pp. 774–775. Smith HA (2017). Forgotten Disease: Illnesses Transformed in Chinese Medicine. doi:10.1093/jhmas/jry029. ISBN 978-1-5036-0350-9. OCLC 993877848.
Mankiewicz (1942), television and film writer; Academy Award nominee for I Want to Live! Steve Krantz (1943), screenwriter and film producer, Fritz the Cat Ernest Kinoy (1947), television writer of Murrow, Roots, and Victory at Entebbe Merrill Brockway (1948), Emmy Award-winning television producer Saul Turteltaub (1954), Emmy Award-nominated television writer and producer William Kronick (1955), film and television writer, director and producer Stephen Schenkel (1956), TV producer, All My Children Milton Moses Ginsberg (1957), director, Coming Apart Doran William Cannon (1959), screenwriter of Skidoo and Brewster McCloud Richard Pearlman (1959), former director of the Washington National Opera as well as the training program at the Lyric Opera of Chicago Terrence McNally (1960), Tony Award-winning playwright; author of Kiss of the Spider Woman and Ragtime Michael Kahn (1961), artistic director of the Shakespeare Theatre Company in Washington, D.C. Brian De Palma (1962), director of Scarface, The Untouchables and Carrie Crawford Kilian (1962), Canadian novelist and professor at Capilano University Thomas H.
Sources: en.wikipedia.org
No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.
No. It has no approved medical indication in any country. Regulatory agencies have not cleared it for treatment or prevention of any condition.
Early clinical work stopped after rodent carcinogenicity findings. Those animal results raised concerns about long-term human risk, although direct human evidence is lacking. The human relevance of the tumors remains an open scientific question.
Anti-doping laboratories typically use LC-MS/MS to detect GW501516 and its metabolites in urine. The method is sensitive and can identify the compound at low concentrations. Detection depends on sample timing, metabolism, and the specific assay.